Examining the relationship between the gelatinolytic balance and the invasive capacity of endothelial cells

Journal of Cell Science

Volumn 112, Issue 9, 1999, Pages 1283-1290

  Puyraimond, Alain ^a   Weitzman, Jonathan B ^b   Babiole, Emeline ^a   Menashi, Suzanne ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b INSTITUT PASTEUR   (France)

Author keywords

Angiogenesis; Endothelial cell; Metalloproteinase; Migration

Indexed keywords

GELATINASE B; MATRIX METALLOPROTEINASE; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; ENDOTHELIUM CELL; NONHUMAN; ONCOGENE C JUN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SECRETION; REGULATORY MECHANISM; TRANSACTIVATION;

ANIMALS; CATTLE; CELL MOVEMENT; ENDOTHELIUM, VASCULAR; GELATINASES; METALLOENDOPEPTIDASES; NEOVASCULARIZATION, PATHOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TETRADECANOYLPHORBOL ACETATE; TISSUE INHIBITOR OF METALLOPROTEINASES; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

ANIMALIA; BOVINAE;

EID: 0033018943     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Alexander, C. M., Hansell, E. J., Behrendtsen, O., Flannery, M. L., Kishnani, N. S., Hawkes, S. P. and Werb, Z. (1996). Expression and function of matrix metalloproteinases and their inhibitors at the maternal-embryonic boundary during mouse embryo implantation. Development 122, 1723-1736.
2. Angel, P. and Karin, M. (1991). The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta 1072, 129-157.
3. Bernhard, E. J., Gruber, S. B. and Muschel, R. J. (1994). Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells. Proc. Nat. Acad. Sci. USA 91, 4293-4297.
4. Bischof, P., Martelli, M., Campana, A., Itoh, Y., Ogata, Y. and Nagase, H. (1995). Importance of matrix metalloproteinases in human trophoblast invasion. Early Pregnancy 1, 263-269.
5. Chambers, A. F. and Matrisian, L. M. (1997). Changing views of the role of matrix matalloproteinases in metastasis. J. Nat. Canc. Inst. 89, 1260-1270.
6. Chiu, R., Angel, P. and Karin, M. (1989). Jun-B differs in its biological properties from, and is a negative regulator of, c-Jun. Cell 59, 979-986.
7. Crawford, H. C. and Matrisian, L. M. (1996). Mechanisms controlling the transcription of matrix metalloproteinase genes in normal and neoplastic cells. Enzyme Protein 49, 20-37.
8. Desrivieres, S., Lu, H., Peyri, N., Soria, C., Legrand, Y. and Menashi, S. (1993). Activation of the 92 kDa type IV collagenase by tissue kallikrein. J. Cell. Physiol. 157, 587-593.
9. Fini, M. E., Bartlett, J. D., Matsubara, M., Rinehart, W. B., Mody, M. K., Girard, M. T. and Rainville, M. (1994). The rabbit gene for 92-kDa matrix metalloproteinase. Role of AP1 and AP2 in cell type-specific transcription. J. Biol. Chem. 269, 28620-28628.
10. Fowlkes, J. L., Enghild, J. J., Suzuki, K. and Nagase, H. (1994). Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures. J. Biol. Chem. 269, 25742-25746.
11. Frandsen, T. L., Boysen, B. E., Jirus, S., Zwiebel, J., Spang-Thomas, M., Thompson, E. W. and Brunner, N. (1992). Assays for the study of human cancer cell invasion and metastasis. Fibrinolysis 6, 71-76.
12. Fridman, R., Toth, M., Pena, D. and Mobashery, S. (1995). Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). Cancer Res. 55, 2548-2555.
13. Galardy, R. E., Grobelny, D., Foellmer, H. G. and Fernandez, L. A. (1994) Inhibition of angiogenesis by the matrix metalloprotease inhibitor N-[2R-2-(hydroxamidocarbonymethyl)-4-methylpentanoyl)]-L-tryptophan methylamide. Cancer Res. 54, 4715-4718.
14. Goodman, S. L., Vollmers, H. P. and Birchmeier, W. (1985). Control of cell locomotion: perturbation with an antibody directed against specific glycoproteins. Cell 41, 1029-1038.
15. Hanahan, D. and Folkman, J. (1996). Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353-364.
16. Heimark, R. L., Twardzik, D. R. and Schwartz, S. M. (1986). Inhibition of endothelial regeneration by type-beta transforming growth factor from platelets. Science 233, 1078-1080.
17. Himelstein, B. P., Canete, S. R., Bernhard, E. J., Dilks, D. W. and Muschel, R. J. (1994). Metalloproteinases in tumor progression: the contribution of MMP-9. Inv. Metast. 14, 246-258.
18. Hiraoka, N., Allen, E., Apel, I. J., Gyetko, M. R. and Weiss, S. J. (1998) Matrix metalloproteinases regulate neovascularisation by acting as pericellular fibrinolysins. Cell 95, 365-377.
19. Itoh, T., Tanioka, M., Yoshida, H., Yoshioka, T., Nishimoto, H. and Itohara, S. (1998). Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res. 58, 1048-1051.
20. Johnson, M. D., Kim, H. R., Chesler, L., Tsao, W. G., Bouck, N. and Polverini, P. J. (1994). Inhibition of angiogenesis by tissue inhibitor of metalloproteinase. J. Cell. Physiol. 160, 194-202.
21. Kerr, L. D., Miller, D. B. and Matrisian, L. M. (1990). TGF-β1 inhibition of transin/stromelysin gene expression is mediated through a Fos binding sequence. Cell 61, 267-278.
22. Kretzschmar, M. and Massague, J. (1998). SMADs: mediators and regulators of TGF-β signaling. Curr. Opin. Genet. Dev. 8, 103-111.
23. Levi, E., Fridman, R., Miao, H. Q., Ma, Y. S., Yayon, A. and Vlodavsky, I. (1996). Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1. Proc. Nat. Acad. Sci. USA 93, 7069-7074.
24. Logan, S. K., Garabedian, M. J., Campbell, C. E. and Werb, Z. (1996). Synergistic transcriptional activation of the tissue inhibitor of metalloproteinases-1 promoter via functional interaction of AP-1 and Ets-1 transcription factors. J. Biol. Chem. 271, 774-782.
25. Madri, J. A., Pratt, B. M. and Tucker, A. M. (1988). Phenotypic modulation of endothelial cells by transforming growth factor-β depends upon the composition and organization of the extracellular matrix. J. Cell Biol. 106, 1375-1384.
26. Matrisian, L. M. (1990). Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet. 6, 121-125.
27. Matrisian, L. M., Ganser, G. L., Kerr, L. D., Pelton, R. W. and Wood, L. D. (1992). Negative regulation of gene expression by TGF-β. Mol. Reprod. Dev. 32, 111-120.
28. Mauviel, A., Chen, Y. Q., Dong, W., Evans, C. H. and Uitto, J. (1993). Transcriptional interactions of transforming growth factor-β with proinflammatory cytokines. Curr. Biol. 3, 822-831.
29. Mauviel, A., Chung, K. Y., Agarwal, A., Tamai, K. and Uitto, J. (1996). Cell-specific induction of distinct oncogenes of the Jun family is responsible for differential regulation of collagenase gene expression by transforming growth factor-β in fibroblasts and keratinocytes. J. Biol. Chem. 271, 10917-10923.
30. Montesano, R. and Orci, L. (1985). Tumor-promoting phorbol esters induce angiogenesis in vitro. Cell 42, 469-477.
31. Montesano, R. and Orci, L. (1987). Phorbol esters induce angiogenesis in vitro from large-vessel endothelial cells. J. Cell. Physiol. 130, 284-291.
32. Muller, G., Behrens, J., Nussbaumer, U., Bohlen, P. and Birchmeier, W. (1987). Inhibitory action of transforming growth factor β on endothelial cells. Proc. Nat. Acad. Sci. USA 84, 5600-5604.
33. Murphy, A. N., Unsworth, E. J. and Stetler-Stevenson, W. G. (1993). Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation. J. Cell. Physiol. 157, 351-358.
34. Murphy, G., Cockett, M. I., Ward, R. V. and Docherty, A. J. (1991). Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP). Biochem. J. 277, 277-279.
35. Ochieng, J., Fridman, R., Nangia-Makker, P., Kleiner, D. E., Liotta, L. A., Stetler-Stevenson, W. G. and Raz, A. (1994). Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and -9. Biochemistry 33, 14109-14114.
36. Oliver, G. W., Leferson, J. D., Stetler-Stevenson, W. G. and Kleiner, D. E. (1997). Quantitative reverse zymography: analysis of picogram amounts of metalloproteinase inhibitors using gelatinase A and B reverse zymograms. Anal. Biochem. 244, 161-166.
37. Olson, M. W., Gervasi, D. C., Mobashery, S. and Fridman, R. (1997). Kinetic analysis of the binding of human matrix metal loproteinase-2 and -9 to tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2. J. Biol. Chem. 272, 29975-29983.
38. Overall, C. M., Wrana, J. L. and Sodek, J. (1991). Transcriptional and post-transcriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor-β1 in human fibroblasts. Comparisons with collagenase and tissue inhibitor of matrix metalloproteinase gene expression. J. Biol. Chem. 266, 14064-14071.
39. Patterson, B. C. and Sang, Q. A. (1997). Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9). J. Biol. Chem. 272, 28823-28825.
40. Pepper, M. S., Belin, D., Montesano, R., Orci, L. and Vassalli, J. D. (1990). Transforming growth factor-β1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro. J. Cell Biol. 111, 743-755.
41. Pepper, M. S., Vassalli, J. D., Orci, L. and Montesano, R. (1993). Biphasic effect of transforming growth factor-β1 on in vitro angiogenesis. Exp. Cell Res. 204, 356-363.
42. Pfarr, C. M., Mechta, F., Spyrou, G., Lallemand, D., Carillo, S. and Yaniv, M. (1994). Mouse JunD negatively regulates fibroblast growth and antagonizes transformation by ras. Cell 76, 747-755.
43. Salo, T., Lyons, J. G., Rahemtulla, F., Birkedal-Hansen, H. and Larjava, H. (1991). Transforming growth factor-β1 up-regulates type IV collagenase expression in cultured human keratinocytes. J. Biol. Chem. 266, 11436-11441.
44. Sato, H. and Seiki, M. (1993). Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 8, 395-405.
45. Schutte, J., Viallet, J., Nau, M., Segal, S., Fedorko, J. and Minna, J. (1989). jun-B inhibits and c-fos stimulates the transforming and trans-activating activities of c-jun. Cell 59, 987-997.
46. Shimizu, S., Nishikawa, Y., Kuroda, K., Takagi, S., Kozaki, K., Hyuga, S., Saga, S. and Matsuyama, M. (1996). Involvement of transforming growth factor β1 in autocrine enhancement of gelatinase B secretion by murine metastatic colon carcinoma cells. Cancer Res. 56, 3366-3367.
47. Stetler-Stevenson, W. G. (1990). Type IV collagenases in tumor invasion and metastasis. Cancer Metast. Rev. 9, 289-303.
48. Taraboletti, G., Garofalo, A., Belotti, D., Drudis, T., Borsotti, P., Scanziani, E., Brown, P. D. and Giavazzi, R. (1995). Inhibition of angiogenesis and murine hemangioma growth by batimastat, a synthetic inhibitor of matrix metalloproteinases. J. Nat. Cancer Inst. 87, 293-298.
49. Uria, J. A., Jimenez, M. G., Balbin, M., Freije, J. M. P. and Lopez-Otin, C. (1998). Differential effects of transforming growth factor-β on the expression of collagenase-1 and collagenase-3 in human fibroblasts. J. Biol. Chem. 273, 9769-9777.
50. Vu, T. H. and Werb, Z. (1998). Gelatinase B: structure, regulation and function. In Matrix Metalloproteinases (ed. W. C. Parks and R. P. Mecham), pp. 115-148. San Diego: Academic Press.
51. Vu, T. H., Shipley, J. M., Bergers, G., Berger, J. E., Helms, J. A., Hanahan, D., Shapiro, S. D., Senior, R. M. and Werb, Z. (1998). MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93, 411-422.
52. Wang, W., Zhou, G., Hu, M. C. T., Yao, Z. and Tan, T. H. (1997). Activation of the hematopoietic progenitor kinase-1 (HPK1)-dependent, stress-activated c-Jun N-terminal kinase (JNK) pathway by transforming growth factor β(TGF-β)-activated kinase (TAK1), a kinase mediator of TGFβ signal transduction. J. Biol. Chem. 272, 22771-22775.
53. Welch, D. R., Fabra, A. and Nakajima, M. (1990). Transforming growth factor β stimulates mammary adenocarcinoma cell invasion and metastatic potential. Proc. Nat. Acad Sci. USA 87, 7678-7682.
54. Yang, E. Y. and Moses, H. L. (1990). Transforming growth factor β1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane. J. Cell Biol. 111, 731-741.